Rossari Biotech Limited (ROSSARI) — Financial Flexibility Index
Rossari Biotech Limited (ROSSARI) has a Financial Flexibility Index of 0.05x as of September 2023. Free cash flow of Rs302.28 Million (operating CF Rs302.28 Million minus capex Rs0.00) represents 0% of total liabilities (Rs5.56 Billion). Check Rossari Biotech Limited (ROSSARI) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rossari Biotech Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Rossari Biotech Limited across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Rossari Biotech Limited generate cash.
Annual Financial Flexibility Index for Rossari Biotech Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Rossari Biotech Limited. Explore Rossari Biotech Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | Rs2.96 Billion | Rs1.37 Billion | Rs7.11 Billion | ▲ +25.1% |
| 2024 | 0.33x | Rs1.75 Billion | Rs432.55 Million | Rs5.24 Billion | ▼ -18.7% |
| 2023 | 0.41x | Rs1.85 Billion | Rs1.52 Billion | Rs4.52 Billion | ▲ +173.6% |
| 2022 | 0.15x | Rs675.83 Million | Rs293.58 Million | Rs4.52 Billion | ▼ -78.4% |
| 2021 | 0.69x | Rs1.06 Billion | Rs477.67 Million | Rs1.53 Billion | ▼ -2.0% |
| 2020 | 0.71x | Rs1.31 Billion | Rs548.28 Million | Rs1.85 Billion | ▼ -22.6% |
| 2019 | 0.91x | Rs1.15 Billion | Rs711.77 Million | Rs1.26 Billion | ▲ +80.2% |
| 2018 | 0.51x | Rs394.94 Million | Rs255.69 Million | Rs778.70 Million | ▲ +306.1% |
| 2017 | 0.12x | Rs86.07 Million | Rs46.95 Million | Rs689.09 Million | — |